Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Falkai

Showing results (181-190 of 226) with videos related to

Pageof 23
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|June 1, 2006
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's diseaseH Kessler, F-G Pajonk, P Meisser, et al.
Journal of Psychiatric Research|July 12, 2020
12- and 18-month follow-up after residential treatment of methamphetamine dependence: Influence of treatment drop-out and different treatment conceptsF Kamp, L Hager, L Proebstl, et al.
Research in Sports Medicine (Print)|July 27, 2019
Running effects on cognition and plasticity (ReCaP): study protocol of a longitudinal examination of multimodal adaptations of marathon runningA Roeh, T Bunse, M Lembeck, et al.
Neuroscience Letters|July 25, 2000
Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy studyW Block, T A Bayer, R Tepest, et al.
Molecular Psychiatry|May 19, 2010
Recombinant human erythropoietin delays loss of gray matter in chronic schizophreniaT Wüstenberg, M Begemann, C Bartels, et al.
Molecular Psychiatry|June 26, 2002
Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illnessK Sawada, C E Young, A M Barr, et al.
Journal of Proteomics|June 21, 2016
Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patientsC C Café-Mendes, E S Ferro, A S Torrão, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 17, 2021
EPA guidance on treatment of negative symptoms in schizophreniaS Galderisi, S Kaiser, I Bitter, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 8, 2014
Evaluation of an integrated care program for schizophrenia: concept and study designL Kerkemeyer, S Mostardt, J Biermann, et al.
Molecular Psychiatry|March 7, 2012
Managing sensitive phenotypic data and biomaterial in large-scale collaborative psychiatric genetic research projects: practical considerationsS Y Demiroglu, D Skrowny, M Quade, et al.
Pageof 23

Showing results (181-190 of 226) with videos related to

Sort By:
Pageof 23
Journal of Neural Transmission (Vienna, Austria : 1996)|June 1, 2006
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's diseaseH Kessler, F-G Pajonk, P Meisser, et al.
Journal of Psychiatric Research|July 12, 2020
12- and 18-month follow-up after residential treatment of methamphetamine dependence: Influence of treatment drop-out and different treatment conceptsF Kamp, L Hager, L Proebstl, et al.
Research in Sports Medicine (Print)|July 27, 2019
Running effects on cognition and plasticity (ReCaP): study protocol of a longitudinal examination of multimodal adaptations of marathon runningA Roeh, T Bunse, M Lembeck, et al.
Neuroscience Letters|July 25, 2000
Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy studyW Block, T A Bayer, R Tepest, et al.
Molecular Psychiatry|May 19, 2010
Recombinant human erythropoietin delays loss of gray matter in chronic schizophreniaT Wüstenberg, M Begemann, C Bartels, et al.
Molecular Psychiatry|June 26, 2002
Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illnessK Sawada, C E Young, A M Barr, et al.
Journal of Proteomics|June 21, 2016
Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patientsC C Café-Mendes, E S Ferro, A S Torrão, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 17, 2021
EPA guidance on treatment of negative symptoms in schizophreniaS Galderisi, S Kaiser, I Bitter, et al.
European Archives of Psychiatry and Clinical Neuroscience|June 8, 2014
Evaluation of an integrated care program for schizophrenia: concept and study designL Kerkemeyer, S Mostardt, J Biermann, et al.
Molecular Psychiatry|March 7, 2012
Managing sensitive phenotypic data and biomaterial in large-scale collaborative psychiatric genetic research projects: practical considerationsS Y Demiroglu, D Skrowny, M Quade, et al.
Pageof 23